Christoph Grevelding of Justus-Liebig-University in Germany will test the effectiveness of Imatinib, a cancer drug which inhibits kinase activity and cellular changes in cells, to impair and kill parasitic worms which carry Schistosomiasis. If successful, Imatinib could serve as a new drug therapy to fight this chronic disease which affects millions in developing countries.
Grant ID
OPP1024324
Show on Hub
On
Show on Spoke
On
Follow-on Funding
Off
Lead Funding Organization
Initiatives
Principal Investigator
Award Manager
Individual Funder Information
Funding Organization
Funding Amount (in original currency)
100000.00
Funding Currency
USD
Funding Amount (in USD)
100000.00
Project Type
Project Primary Sector
Project Subsector
Funding Date Range
-
Funding Total (In US dollars)
100000.00
Co-Funded
False